The Top 5 Biosimilar Articles for the Week of February 27

Video

Here are the top 5 biosimilar articles for the week of February 27, 2023.

Hi, I’m Justina Petrullo for The Center for Biosimilars®, your resource for clinical, regulatory, business, and policy news in the rapidly changing world of biosimilars.

Here are the top 5 biosimilar articles for the week of February 27th, 2023.

Number 5: In Cardinal Health’s 2023 Biosimilars Report, more than 60% of surveyed providers said they would only want to prescribe adalimumab biosimilars with interchangeability designations, suggesting the label may have a greater impact on uptake than originally expected.

Number 4: In theory, by offering a lower-cost treatment option, biosimilars would help drive access for countless patients who simply could not afford the brand-name biologic. However, biosimilars have also encountered the harsh realities of the US health care system and its market forces.

Number 3: Panelists at the annual meeting of the International Generic and Biosimilar Medicines Association (IGBA) offered insight into the current state of the global biosimilar and generic markets and why government agencies need to leverage these medicines to address challenges in the pharmaceutical space.

Number 2: Fresenius Kabi announced a global partnership with Formycon for an ustekinumab biosimilar; Similis Bio partners with Novel351K to co-develop 3 biosimilars; and Celltrion Healthcare launched its bevacizumab biosimilar in Japan.

Number 1: Jacqueline Corrigan-Curay, MD, JD, principal deputy center director of the FDA's Center for Drug Evaluation and Research, gave a keynote presentation at Access 2023 on how the Biosimilar User Fee Act and the Generic Drug User Fee Act have developed over the last year.

To read all of these articles and more, visit centerforbiosimilars.com.

Related Videos
Here are the top 5 biosimilar articles for the week of September 18, 2023.
Here are the top 5 biosimilar articles for the week of September 11, 2023.
Fran Gregory, PharmD, MBA
Here are the top 5 biosimilar articles for the week of August 28, 2023.
Here are the top 5 biosimilar articles for the week of August 28, 2023.
Fran Gregory, PharmD, MBA
Here are the top 5 biosimilar articles for the week of August 21, 2023.
Here are the top 5 biosimilar articles for the week of August 14, 2023.
Related Content
© 2023 MJH Life Sciences

All rights reserved.